"Hypertension and renal risk"@en . "1" . . "Arteri\u00E1ln\u00ED hypertenze je v\u00FDznamn\u00FDm l\u00E9\u010Dbou ovlivniteln\u00FDm faktorem rizika jak vzniku chronick\u00E9ho onemocn\u011Bn\u00ED ledvin v obecn\u00E9 populaci, tak progrese ren\u00E1ln\u00EDho posti\u017Een\u00ED p\u0159i ji\u017E existuj\u00EDc\u00EDm chronick\u00E9m onemocn\u011Bn\u00ED ledvin u diabetick\u00FDch i nediabetick\u00FDch pacient\u016F. Nep\u0159\u00EDzniv\u00FD vliv vysok\u00E9ho krevn\u00EDho tlaku, hlavn\u011B systolick\u00E9ho a pulzn\u00EDho, se uplat\u0148uje v kontextu s ostatn\u00EDmi rizikov\u00FDmi faktory, p\u0159edev\u0161\u00EDm pak s albuminuri\u00ED nebo proteinuri\u00ED. Jak hypertenze bez rozd\u00EDlu etiologie (prim\u00E1rn\u00ED nebo ren\u00E1ln\u00ED), tak i existence chronick\u00E9ho onemocn\u011Bn\u00ED ledvin, vede k propojen\u00ED ren\u00E1ln\u00EDho rizika s rizikem kardiovaskul\u00E1rn\u00EDm. Pro ovlivn\u011Bn\u00ED ren\u00E1ln\u00EDho rizika je d\u016Fle\u017Eit\u00E9 v\u010Dasn\u00E9 zji\u0161t\u011Bn\u00ED, spr\u00E1vn\u00E9 zhodnocen\u00ED a \u00FA\u010Dinn\u00E1 l\u00E9\u010Dba hypertenze. Pou\u017Eit\u00ED jak 24 hodinov\u00E9 monitorace, tak i dom\u00E1c\u00EDho m\u011B\u0159en\u00ED krevn\u00EDho tlaku je p\u0159\u00EDnosn\u00E9 z hlediska diagnostick\u00E9ho, l\u00E9\u010Debn\u00E9ho i prognostick\u00E9ho. Pro odhad individu\u00E1ln\u00EDho ren\u00E1ln\u00EDho rizika je nezbytn\u00E9 posouzen\u00ED hypertenze s dal\u0161\u00EDmi dostupn\u00FDmi klinick\u00FDmi, laboratorn\u00EDmi a p\u0159\u00EDpadn\u011B morfologick\u00FDmi n\u00E1lezy."@cs . . . "Hypertenze a ren\u00E1ln\u00ED riziko"@cs . "Hypertenze a ren\u00E1ln\u00ED riziko"@cs . . "6"^^ . . "1"^^ . "Monhart, V\u00E1clav" . . "CZ - \u010Cesk\u00E1 republika" . . "RIV/61383082:_____/09:#0000042!RIV10-MO0-61383082" . "Hypertension and renal risk"@en . "V" . "3" . "Hypertension"@en . "Hypertenze a ren\u00E1ln\u00ED riziko" . "318220" . "1"^^ . . "Arterial hypertension is important and treatable risk factor both for development of chronic kidney disease in general population and progression of renal injury in pre-exist chronic kidney disease in diabetic and non-diabetic patients. Unfavourable efect of hypertension, mainly systolic and pulse blood pressure, is asserted in context of other risk factors especially albuminuria and proteinuria."@en . . "RIV/61383082:_____/09:#0000042" . . "Arteri\u00E1ln\u00ED hypertenze je v\u00FDznamn\u00FDm l\u00E9\u010Dbou ovlivniteln\u00FDm faktorem rizika jak vzniku chronick\u00E9ho onemocn\u011Bn\u00ED ledvin v obecn\u00E9 populaci, tak progrese ren\u00E1ln\u00EDho posti\u017Een\u00ED p\u0159i ji\u017E existuj\u00EDc\u00EDm chronick\u00E9m onemocn\u011Bn\u00ED ledvin u diabetick\u00FDch i nediabetick\u00FDch pacient\u016F. Nep\u0159\u00EDzniv\u00FD vliv vysok\u00E9ho krevn\u00EDho tlaku, hlavn\u011B systolick\u00E9ho a pulzn\u00EDho, se uplat\u0148uje v kontextu s ostatn\u00EDmi rizikov\u00FDmi faktory, p\u0159edev\u0161\u00EDm pak s albuminuri\u00ED nebo proteinuri\u00ED. Jak hypertenze bez rozd\u00EDlu etiologie (prim\u00E1rn\u00ED nebo ren\u00E1ln\u00ED), tak i existence chronick\u00E9ho onemocn\u011Bn\u00ED ledvin, vede k propojen\u00ED ren\u00E1ln\u00EDho rizika s rizikem kardiovaskul\u00E1rn\u00EDm. Pro ovlivn\u011Bn\u00ED ren\u00E1ln\u00EDho rizika je d\u016Fle\u017Eit\u00E9 v\u010Dasn\u00E9 zji\u0161t\u011Bn\u00ED, spr\u00E1vn\u00E9 zhodnocen\u00ED a \u00FA\u010Dinn\u00E1 l\u00E9\u010Dba hypertenze. Pou\u017Eit\u00ED jak 24 hodinov\u00E9 monitorace, tak i dom\u00E1c\u00EDho m\u011B\u0159en\u00ED krevn\u00EDho tlaku je p\u0159\u00EDnosn\u00E9 z hlediska diagnostick\u00E9ho, l\u00E9\u010Debn\u00E9ho i prognostick\u00E9ho. Pro odhad individu\u00E1ln\u00EDho ren\u00E1ln\u00EDho rizika je nezbytn\u00E9 posouzen\u00ED hypertenze s dal\u0161\u00EDmi dostupn\u00FDmi klinick\u00FDmi, laboratorn\u00EDmi a p\u0159\u00EDpadn\u011B morfologick\u00FDmi n\u00E1lezy." . "Pokroky v oboru nefrologie" . . "Hypertenze a ren\u00E1ln\u00ED riziko" . "1211-7943" . . "[CFC7CC78D80D]" .